The largest community of pharma leaders

Clinical Trial Data Analytics Helped a Pharma Company to Determine Chance of Disease Relapse | A Quantzig Success Story

LONDON–()–As a part of its new healthcare provider analytics article series, Quantzig, a premier analytics services provider, today announced the completion of its recent case study- ‘How Clinical Trial Data Analytics Helped a Leading Global Pharma Company to Determine Chance of Disease Relapse‘

The case study also offers comprehensive insights on:

  1. The benefits of clinical trial data analytics
  2. Why pharma companies should leverage clinical data analytics to improve their services

Quantzig’s analytics experts help pharmaceutical companies to optimize strategic clinical processes by combining data, analytics and technology. Get in touch with them to know more.

For companies in the pharmaceutical industry, it is difficult to analyze the vast amounts of raw, unstructured patient data. Clinical trial data analysis requires tested statistical methods that have to be specified with the regulatory authorities before the trial even begins. With nearly 80% of clinical trials failing to meet enrollment timelines, pharmaceutical companies need a more efficient approach to improve their data analysis capability.

At Quantzig, we analyze the current business scenario using real-time dashboards to help global enterprises operate more efficiently. Our ability to help performance-driven organizations realize their strategic and operational goals within a short span using data-driven insights has helped us gain a leading edge in the analytics industry. To help businesses ensure business continuity amid the crisis, we’ve curated a portfolio of advanced healthcare provider analytics solutions that not just focus on improving profitability but help enhance stakeholder value, boost customer satisfaction, and help achieve financial objectives.

Want comprehensive solution insights from an expert who decodes data? You’re just a click away! Request FREE demo to discover how our seasoned analytics experts can help you.

“Clinical trial data analysis done using data analytics tools can help pharmaceutical companies to understand the epidemiology landscape and develop an effective enrollment forecast,” says a clinical data analytics expert at Quantzig.

Quantzig’s clinical trial data analysis engagement helped the client to:

  • Reduce the risk of multiple surgeries
  • Predict the optimal therapy line as well as medication-based on model results
  • Evaluate the effectiveness of the prescribed medication

The solution offered helped the client to gain valuable insights into adverse events, patient characteristics, and segments level. Also, the client was able to improve their patient data quality check mechanism by highlighting current inefficiencies in the data entry process. Our clinical trial data analysis solutions help companies to analyze performance with access to critical trial data in real-time. Request a free proposal to gain in-depth insights into our portfolio of analytics solutions.

Quantzig’s Healthcare Analytics Capabilities Include:

  1. Clinical trial reporting and analytics
  2. Pharmacovigilance analytics
  3. Drug pricing and promotion analytics
  4. Patient analytics

To know more about our healthcare provider analytics solutions, visit: https://bit.ly/3coJSlM

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal

Source

0FansLike
0FollowersFollow
0FollowersFollow
0FollowersFollow

Recent Articles

bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory Board

SAN ANTONIO--(BUSINESS WIRE)-- #CyPathLung--bioAffinity Technologies, a privately held biotech company, today...

Evaluate Ltd. Launches Evaluate Omnium, Transforming Pharma’s Approach to Quantifying the Risk and Return of Novel Drugs

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)-- #biopharma--Evaluate Ltd., the leading provider...

HCPLive® and the American Lung Association Unveil Exclusive Interview with Anthony S. Fauci, M.D.

CRANBURY, N.J.--(BUSINESS WIRE)-- #AnthonyFauci--Dr. Anthony Fauci joined Lungcast, the @MDMagazine and...

MedinCell Initiates the First Clinical Trial of Its Covid-19 Prevention Program

MONTPELLIER, France--(BUSINESS WIRE)--MedinCell (Paris:MEDCL): Access the complete press release About MedinCell...

CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China

SUZHOU, China--(BUSINESS WIRE)--CStone Pharmaceuticals (“CStone”, HKEX: 2616)] and Pfizer Investment Co....
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.